Genetic testing for pharmacogenetics and its clinical application in drug therapy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CCCN.2005.05.047PMID 16126184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SNP typing on the NanoChip electronic microarray.

  2005cited by this paper
• Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons.

  2004cited by this paper
• Flow Cytometric Assay for Genotyping Cytochrome P450 2C9 and 2C19

  2004cited by this paper
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

  2004cited by this paper
• Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye.

  2004cited by this paper
• Combination allele-specific real-time PCR for differentiation of beta 2-adrenergic receptor coding single-nucleotide polymorphisms.

  2004cited by this paper
• CYP3A5 Genotype and Midazolam Clearance in Australian Patients Receiving Chemotherapy

  2004cited by this paper
• Genotyping of single nucleotide polymorphisms (SNPs) influencing drug response by competitive allele-specific short oligonucleotide hybridization (CASSOH) with immunochromatographic strip.

  2004cited by this paper
• EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

  2004cited by this paper
• Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

  2004cited by this paper
• Leukotriene C4 synthase polymorphism analysis with the 5' fluorogenic exonuclease (TaqMan) assay.

  2004cited by this paper
• N-acetyltransferase 2 genotyping: an accurate and feasible approach for simultaneous detection of the most common NAT2 alleles.

  2004cited by this paper
• Anticancer drugs: To the rescue?

  2004cited by this paper
• Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR.

  2003cited by this paper
• Detection of the four sequence variations of MDR1 gene using TaqMan MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects.

  2003cited by this paper
• Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing

  2003cited by this paper
• The Use of Denaturing High-Performance Liquid Chromatography (DHPLC) for the Analysis of Genetic Variations: Impact for Diagnostics and Pharmacogenetics

  2003cited by this paper
• Detection of single nucleotide substitution by competitive allele‐specific short oligonucleotide hybridization (CASSOH) with immunochromatographic strip

  2003cited by this paper
• Pharmacogenetics goes genomic

  2003cited by this paper
• Enhanced allele‐specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers

  2003cited by this paper
• CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real‐rime PCR

  2003cited by this paper
• A simultaneous LightCycler detection assay for five genetic polymorphisms influencing drug sensitivity.

  2002cited by this paper
• Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

  2002cited by this paper
• Genotyping of the N-acetyltransferase2 polymorphism in the prediction of adverse drug reactions to isoniazid in Japanese patients.

  2002cited by this paper
• Polymorphism of the N‐acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug–induced hepatitis

  2002cited by this paper
• SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery.

  2002cited by this paper
• Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population

  2002cited by this paper
• Characterization of cytochrome P450 2D6 alleles using the Invader system.

  2002cited by this paper
• HyBeacon probes: a new tool for DNA sequence detection and allele discrimination.

  2001cited by this paper
• High-throughput genomic and proteomic analysis using microarray technology.

  2001cited by this paper
• Fluorescence-based detection of the CETP TaqIB polymorphism: false positives with the TaqMan-based exonuclease assay attributable to a previously unknown gene variant.

  2001cited by this paper
• Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

  2001cited by this paper
• No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.

  2001cited by this paper
• Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms.

  2001cited by this paper
• Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer.

  2001cited by this paper
• Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, "two-color/shared" anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design.

  2000cited by this paper
• Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.

  2000cited by this paper
• Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

  2000cited by this paper
• A method for homogeneous color-compensated genotyping of factor V (G1691A) and methylenetetrahydrofolate reductase (C677T) mutations using real-time multiplex fluorescence PCR.

  2000cited by this paper
• Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.

  2000cited by this paper
• Known variant DPYD alleles do not explain DPD deficiency in cancer patients.

  2000cited by this paper
• High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5' nuclease chain reaction assay.

  2000cited by this paper
• CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10.

  2000cited by this paper
• Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction.

  2000cited by this paper
• CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates.

  2000cited by this paper
• Loop-mediated isothermal amplification of DNA.

  2000cited by this paper
• Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

  2000cited by this paper
• Technologies for detecting genetic polymorphisms in pharmacogenomics.

  1999cited by this paper
• Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele.

  1999cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

  1999cited by this paper
• A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype.

  1999cited by this paper
• Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green.

  1999cited by this paper
• Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism

  1999cited by this paper
• Chip-based genotyping by mass spectrometry.

  1999cited by this paper
• Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes.

  1999cited by this paper
• Clinical, genetic, and pharmacogenetic applications of the Invader assay.

  1999cited by this paper
• The hereditary transmission of the glutathione transferase hGSTT1-1 conjugator phenotype in a large family.

  1999cited by this paper
• Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.

  1999cited by this paper
• Rapid mass screening method and counseling for the 1555A→G mitochondrial mutation

  1999cited by this paper
• Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler.

  1999cited by this paper
• CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

  1999cited by this paper
• Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.

  1998cited by this paper
• Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes.

  1998cited by this paper
• Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer

  1998cited by this paper
• Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes

  1998cited by this paper
• Nomenclature for human DPYD alleles.

  1998cited by this paper
• Pharmacogenetics of cancer therapy: getting personal.

  1998cited by this paper
• CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans.

  1998cited by this paper
• Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions

  1997cited by this paper
• Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR.

  1997cited by this paper
• Genotyping of N‐acetylation polymorphism and correlation with procainamide metabolism

  1997cited by this paper
• Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects.

  1996cited by this paper
• Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.

  1996cited by this paper
• Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects

  1996cited by this paper
• Nomenclature for human CYP2D6 alleles.

  1996cited by this paper
• Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.

  1995cited by this paper
• [Population study of dihydropyrimidine dehydrogenase in cancer patients].

  1994cited by this paper
• Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

  1994cited by this paper
• Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.

  1994cited by this paper
• A molecular and cellular hypothesis for aminoglycoside-induced deafness.

  1994cited by this paper
• Population study of dihydropyrimidine dehydrogenase in cancer patients.

  1994cited by this paper
• Thiopurine methyltransferase activity in American white subjects and black subjects

  1994cited by this paper
• Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness

  1993cited by this paper
• N-acetyltransferase.

  1989cited by this paper

• Exploration of Canarium odontophyllum fruit phytoconstituents as potential candidates against epilepsy using in silico studies

  2025cites this paper
• The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics.

  2023cites this paper
• Expression pattern of heat shock protein genes in sheep

  2020cites this paper
• Biomarkers

  2020cites this paper
• A Use Case to Support Precision Medicine for Frequently Hospitalized Older Adults with Polypharmacy

  2016cites this paper
• Screening study for genetic polymorphisms affecting pharmacokinetics of pioglitazone

  2016cites this paper
• Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians

  2016cites this paper
• Potential utility of precision medicine for older adults with polypharmacy: a case series study

  2016cites this paper
• Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study

  2016cites this paper
• Exploring Responsible Neuroimaging Innovation: Visions From a Societal Actor Perspective

  2016cites this paper
• Screening study for genetic polymorphisms affecting pharmacokinetics of simvastatin

  2016cites this paper
• Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data.

  2014cites this paper
• Single-channel multiplexing without melting curve analysis in real-time PCR

  2014cites this paper
• High-throughput genotyping system as a robust and useful tool in oncology: experience from a single institution.

  2013cites this paper
• A study on Pharmacogenetic polymorphisms in the Portuguese Gypsies

  2013cites this paper
• ファーマコゲノミクス（PGx）情報を利用した個別化薬物療法の展開

  2012cites this paper
• Pharmacogenomics in Personalized Drug Therapy

  2012cites this paper
• Pharmacogenetics: The Scientific Basis

  2012cites this paper
• DNA amplification techniques in pharmacogenomics.

  2011cites this paper
• Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?

  2011cites this paper
• The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications

  2011cites this paper
• GENETIC VARIABILITY AND INTERETHNIC DIFFERENCES OF SELECTED PHARMACOGENETICALLY RELEVANT GENES IN AVERAGE HUNGARIAN AND ROMA POPULATION SAMPLES Doctoral (Ph.D.) thesis

  2010cites this paper
• Les enjeux de la translation des technologies : le cas des testsde pharmacogénétique au Québec

  2010cites this paper
• GENETIC VARIABILITY AND INTERETHNIC DIFFERENCES OF SELECTED PHARMACOGENETICALLY RELEVANT GENES IN AVERAGE HUNGARIAN AND

  2010cites this paper
• Genetic Influences on Neural Plasticity

  2010cites this paper
• NBD‐Based Green Fluorescent Ligands for Typing of Thymine‐Related SNPs by Using an Abasic Site‐Containing Probe DNA

  2009cites this paper
• Brain Plasticity and Genetic Factors

  2009cites this paper
• Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine

  2008cites this paper
• In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?

  2008cites this paper
• Development of an automated identification system for nano-crystal encoded microspheres in flow cytometry

  2008cites this paper
• Mitochondria as a target for novel chemotherapeutic agents based on phenolic acids

  2008cites this paper
• Beyond single nucleotide polimorphism

  2008cites this paper
• Towards genetic markers in animal populations as biomonitors for human-induced environmental change.

  2007cites this paper
• Molecular-based choice of cancer therapy: realities and expectations.

  2007cites this paper
• Sonden zur Detektion des UGT1A1-Gens, Reagenz davon zur Detektion des UGT1A1-Gens, und ihre Verwendungen

  2007cites this paper
• A novel buffer system, AnyDirect, can improve polymerase chain reaction from whole blood without DNA isolation.

  2007cites this paper
• Relevance of pharmacogenetic aspects of mercaptopurine metabolism in the treatment of interstitial lung disease

  2007cites this paper
• Direct amplification from various biospecimens using a novel PCR buffer system

  2007cites this paper
• A novel SNP detection technique utilizing a multiple primer extension (MPEX) on a phospholipid polymer-coated surface.

  2007cites this paper
• Comparación de los genotipos CYP2C19 entre caucásico español y mestizo colombiano

  2006cites this paper
• DA BIOLOGIA MOLECULAR MEDICINA: MTODOS COMUMENTE UTILIZADOS EM FARMACOGENTICA

  2006cites this paper
• PHARMACOGENETICS APPROACH TO THERAPEUTICS

  2006cites this paper
• Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine

  2006cites this paper
• The growth of a lie and the end of "conventional" medicine.

  2005cites this paper
• Pharmacogenomics and Hope for Individualized Medicine

  year unknowncites this paper
• Journal of Theoretical & Experimental Pharmacology

  year unknowncites this paper